Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells

Title:Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells

Volume: 24 Issue: 5

Author(s): Xiaojie Huang, Tianming Lian, Xiaoqian Guan, Bin Liu, Siyuan Hao, Jingjing Zhang*, Shiting Bao*, Xiaoyu Tan*Runzhi Zhu*

Affiliation:

• Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001,China

• Laboratory of Hepatobiliary Surgery, Guangdong Medical University; Zhanjiang Key Laboratory of Hepatobiliary Disease,China

• Laboratory of Hepatobiliary Surgery, Guangdong Medical University; Zhanjiang Key Laboratory of Hepatobiliary Disease,China

• Laboratory of Hepatobiliary Surgery, Guangdong Medical University; Zhanjiang Key Laboratory of Hepatobiliary Disease and Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001,China

Keywords: Dihydromyricetin, anti-cancer, proliferation, apoptosis, P53, hepatocellular carcinoma.

Abstract: Natural antineoplastic drug development is crucial to treatment of clinical oncology. Dihydromyricetin, a bioactive flavonoid compound was extracted from the stems and leaves of Ampelopsis grossedentata. It exhibited anticancer activity and induced apoptosis in human hepatocellular carcinoma cells according to our previous studies. In this study, we demonstrated that DHM could significantly inhibit proliferation and induce apoptosis in HepG2 cells with MTT and Flow Cytometry methods. It is very interesting that we found DHM could regulate TGF-β signal pathway and which has a crosstalk with P53, Smad3 and P-Smad2/3 proteins. Meanwhile, we confirmed that DHM showed antitumor activity by regulating the activation of the p53-dependent pathways (MDM2, P-MDM2, BAX and Bcl-2). These findings defined and supported a novel mechanism that DHM could induce cell apoptosis by reducing TGF-β via p53 signal pathway in HepG2 cells.

Cite this article as:

Huang Xiaojie, Lian Tianming, Guan Xiaoqian, Liu Bin, Hao Siyuan, Zhang Jingjing*, Bao Shiting*, Tan Xiaoyu*, Zhu Runzhi*, Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells, Protein & Peptide Letters 2017; 24 (5) . https://dx.doi.org/10.2174/0929866524666170223143113